Sunosi

Sunosi Warnings and Precautions

• Blood pressure and heart rate increases: Sunosi can increase blood pressure and heart rate; these should be monitored, especially in patients with pre-existing cardiovascular conditions.
• Not for airway obstruction: Sunosi does not treat the underlying cause of OSA; airway obstruction should be managed separately.
• Psychiatric symptoms: Anxiety, irritability, and insomnia have been reported.
• Abuse and dependence potential: As a Schedule IV controlled substance, patients with a history of substance abuse should be monitored carefully.

How to Access Sunosi in India: A 6-Step Process

Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.

Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.

Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.

Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.

Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant conditions to maintain product integrity.

Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.

Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.

Documentation & Availability

What documents are required to import Sunosi to India?

Sunosi (solriamfetol) tablets may be imported in the patient's name only, by patients or government hospitals, in line with India's import regulations for unapproved medicines. As a Schedule IV controlled substance in the country of origin, additional documentation may apply. The following documentation is required:

• A valid prescription from a qualified physician or sleep specialist
• The patient's diagnostic reports confirming narcolepsy or obstructive sleep apnea
• Patient ID proof (issued by the Government of India)

How is the order confirmed?

The order is confirmed only after receipt and verification of a valid prescription from the doctor and, if applicable, an import permit.

Is Sunosi available in India?

Sunosi (solriamfetol tablets) is a prescription medicine that legally requires a doctor's prescription to be dispensed. As of current publicly available information, Sunosi is not commercially marketed in India.

However, patients in India can legally access Sunosi through the Named Patient Program (NPP) — an import provision that allows patients to receive medicines approved in other countries but not yet marketed in India, under a doctor's prescription and proper regulatory documentation.

Sunosi received US FDA approval in 2019 to improve wakefulness in patients with excessive daytime sleepiness due to narcolepsy or OSA, ensuring full transparency throughout the process.

Sunosi can be made available to patients, doctors, and hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others.

Sourcing & Delivery of Sunosi

Sunosi is sourced directly from authorized channels in the country of origin and shipped to India under GDP-compliant logistics to preserve product integrity from dispatch to delivery.

• Storage maintained at 15°C to 30°C throughout transit
• Real-time shipment tracking and delivery updates
• Delivery coordinated directly with the patient, family, or treating hospital

Availability of Sunosi Across Major Cities in India

Named Patient Program supports access to Sunosi for patients with narcolepsy or OSA-related excessive daytime sleepiness across major cities in India, coordinating documentation, sourcing, and delivery with treating physicians.

Mumbai

Patients in Mumbai can access Sunosi through NPP with support from treating sleep specialists and neurologists.

Delhi

In Delhi, NPP coordinates with hospitals and specialty sleep clinics to facilitate timely access to Sunosi.

Bangalore

Bangalore's sleep medicine centers work with NPP to support patients requiring Sunosi.

Chennai

Patients in Chennai can access Sunosi through NPP, with coordination between treating doctors and the program's regulatory and logistics team.

Hyderabad

Hyderabad's sleep medicine centers support diagnosis and access coordination for Sunosi through NPP.

Kolkata

NPP facilitates access to Sunosi for patients in Kolkata under the guidance of treating physicians.

Pune

Patients in Pune can access Sunosi through NPP with prescription-based coordination and delivery support.

Ahmedabad

NPP supports access to Sunosi for patients in Ahmedabad, working directly with treating specialists.

Kochi

Patients in Kochi and across Kerala can access Sunosi through NPP's regulated import pathway.

Chandigarh

NPP coordinates access to Sunosi for patients in Chandigarh and the surrounding region.

Jaipur

Patients in Jaipur can access Sunosi through NPP with support from treating physicians.

Lucknow

NPP facilitates access to Sunosi for patients in Lucknow and across Uttar Pradesh.

Bhubaneswar

Patients in Bhubaneswar can access Sunosi through NPP's coordinated import and delivery process.

Guwahati

NPP supports access to Sunosi for patients in Guwahati and across the Northeast region.

NPP also supports access for patients in other Indian cities not listed above — contact the team to check availability and timelines for your location.